Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking

Joshua M. Lorenz-Guertin, Matthew J. Bambino, Sabyasachi Das, Susan E Weintraub, Tija C. Jacob

Research output: Contribution to journalArticle

Abstract

Despite 50+ years of clinical use as anxiolytics, anti-convulsants, and sedative/hypnotic agents, the mechanisms underlying benzodiazepine (BZD) tolerance are poorly understood. BZDs potentiate the actions of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the adult brain, through positive allosteric modulation of γ 2 subunit containing GABA type A receptors (GABAARs). Here we define key molecular events impacting γ 2 GABAAR and the inhibitory synapse gephyrin scaffold following initial sustained BZD exposure in vitro and in vivo. Using immunofluorescence and biochemical experiments, we found that cultured cortical neurons treated with the classical BZD, diazepam (DZP), presented no substantial change in surface or synaptic levels of γ 2-GABAARs. In contrast, both γ 2 and the postsynaptic scaffolding protein gephyrin showed diminished total protein levels following a single DZP treatment in vitro and in mouse cortical tissue. We further identified DZP treatment enhanced phosphorylation of gephyrin Ser270 and increased generation of gephyrin cleavage products. Selective immunoprecipitation of γ 2 from cultured neurons revealed enhanced ubiquitination of this subunit following DZP exposure. To assess novel trafficking responses induced by DZP, we employed a γ 2 subunit containing an N terminal fluorogen-activating peptide (FAP) and pH-sensitive green fluorescent protein (γ 2pHFAP). Live-imaging experiments using γ 2pHFAP GABAAR expressing neurons identified enhanced lysosomal targeting of surface GABAARs and increased overall accumulation in vesicular compartments in response to DZP. Using fluorescence resonance energy transfer (FRET) measurements between α 2 and γ 2 subunits within a GABAAR in neurons, we identified reductions in synaptic clusters of this subpopulation of surface BZD sensitive receptor. Additional time-series experiments revealed the gephyrin regulating kinase ERK was inactivated by DZP at multiple time points. Moreover, we found DZP simultaneously enhanced synaptic exchange of both γ 2-GABAARs and gephyrin using fluorescence recovery after photobleaching (FRAP) techniques. Finally we provide the first proteomic analysis of the BZD sensitive GABAAR interactome in DZP vs. vehicle treated mice. Collectively, our results indicate DZP exposure elicits down-regulation of gephyrin scaffolding and BZD sensitive GABAAR synaptic availability via multiple dynamic trafficking processes.

Original languageEnglish (US)
Article number163
JournalFrontiers in Cellular Neuroscience
Volume13
DOIs
StatePublished - Apr 12 2019

Fingerprint

GABA-A Receptors
Diazepam
Benzodiazepines
Neurons
Fluorescence Recovery After Photobleaching
Convulsants
Fluorescence Resonance Energy Transfer
GABA Receptors
Ubiquitination
Anti-Anxiety Agents
Green Fluorescent Proteins
gephyrin
Hypnotics and Sedatives
Immunoprecipitation
Proteomics
Synapses
gamma-Aminobutyric Acid
Fluorescent Antibody Technique
Neurotransmitter Agents
Proteins

Keywords

  • Benzodiazepine
  • Diazepam
  • GABAR
  • Gephyrin
  • Inhibitory synapse
  • Mass spectrometry
  • Trafficking

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking. / Lorenz-Guertin, Joshua M.; Bambino, Matthew J.; Das, Sabyasachi; Weintraub, Susan E; Jacob, Tija C.

In: Frontiers in Cellular Neuroscience, Vol. 13, 163, 12.04.2019.

Research output: Contribution to journalArticle

Lorenz-Guertin, Joshua M. ; Bambino, Matthew J. ; Das, Sabyasachi ; Weintraub, Susan E ; Jacob, Tija C. / Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking. In: Frontiers in Cellular Neuroscience. 2019 ; Vol. 13.
@article{6d2b42ebe8eb46418140b36edccc1d1c,
title = "Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking",
abstract = "Despite 50+ years of clinical use as anxiolytics, anti-convulsants, and sedative/hypnotic agents, the mechanisms underlying benzodiazepine (BZD) tolerance are poorly understood. BZDs potentiate the actions of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the adult brain, through positive allosteric modulation of γ 2 subunit containing GABA type A receptors (GABAARs). Here we define key molecular events impacting γ 2 GABAAR and the inhibitory synapse gephyrin scaffold following initial sustained BZD exposure in vitro and in vivo. Using immunofluorescence and biochemical experiments, we found that cultured cortical neurons treated with the classical BZD, diazepam (DZP), presented no substantial change in surface or synaptic levels of γ 2-GABAARs. In contrast, both γ 2 and the postsynaptic scaffolding protein gephyrin showed diminished total protein levels following a single DZP treatment in vitro and in mouse cortical tissue. We further identified DZP treatment enhanced phosphorylation of gephyrin Ser270 and increased generation of gephyrin cleavage products. Selective immunoprecipitation of γ 2 from cultured neurons revealed enhanced ubiquitination of this subunit following DZP exposure. To assess novel trafficking responses induced by DZP, we employed a γ 2 subunit containing an N terminal fluorogen-activating peptide (FAP) and pH-sensitive green fluorescent protein (γ 2pHFAP). Live-imaging experiments using γ 2pHFAP GABAAR expressing neurons identified enhanced lysosomal targeting of surface GABAARs and increased overall accumulation in vesicular compartments in response to DZP. Using fluorescence resonance energy transfer (FRET) measurements between α 2 and γ 2 subunits within a GABAAR in neurons, we identified reductions in synaptic clusters of this subpopulation of surface BZD sensitive receptor. Additional time-series experiments revealed the gephyrin regulating kinase ERK was inactivated by DZP at multiple time points. Moreover, we found DZP simultaneously enhanced synaptic exchange of both γ 2-GABAARs and gephyrin using fluorescence recovery after photobleaching (FRAP) techniques. Finally we provide the first proteomic analysis of the BZD sensitive GABAAR interactome in DZP vs. vehicle treated mice. Collectively, our results indicate DZP exposure elicits down-regulation of gephyrin scaffolding and BZD sensitive GABAAR synaptic availability via multiple dynamic trafficking processes.",
keywords = "Benzodiazepine, Diazepam, GABAR, Gephyrin, Inhibitory synapse, Mass spectrometry, Trafficking",
author = "Lorenz-Guertin, {Joshua M.} and Bambino, {Matthew J.} and Sabyasachi Das and Weintraub, {Susan E} and Jacob, {Tija C.}",
year = "2019",
month = "4",
day = "12",
doi = "10.3389/fncel.2019.00163",
language = "English (US)",
volume = "13",
journal = "Frontiers in Cellular Neuroscience",
issn = "1662-5102",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking

AU - Lorenz-Guertin, Joshua M.

AU - Bambino, Matthew J.

AU - Das, Sabyasachi

AU - Weintraub, Susan E

AU - Jacob, Tija C.

PY - 2019/4/12

Y1 - 2019/4/12

N2 - Despite 50+ years of clinical use as anxiolytics, anti-convulsants, and sedative/hypnotic agents, the mechanisms underlying benzodiazepine (BZD) tolerance are poorly understood. BZDs potentiate the actions of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the adult brain, through positive allosteric modulation of γ 2 subunit containing GABA type A receptors (GABAARs). Here we define key molecular events impacting γ 2 GABAAR and the inhibitory synapse gephyrin scaffold following initial sustained BZD exposure in vitro and in vivo. Using immunofluorescence and biochemical experiments, we found that cultured cortical neurons treated with the classical BZD, diazepam (DZP), presented no substantial change in surface or synaptic levels of γ 2-GABAARs. In contrast, both γ 2 and the postsynaptic scaffolding protein gephyrin showed diminished total protein levels following a single DZP treatment in vitro and in mouse cortical tissue. We further identified DZP treatment enhanced phosphorylation of gephyrin Ser270 and increased generation of gephyrin cleavage products. Selective immunoprecipitation of γ 2 from cultured neurons revealed enhanced ubiquitination of this subunit following DZP exposure. To assess novel trafficking responses induced by DZP, we employed a γ 2 subunit containing an N terminal fluorogen-activating peptide (FAP) and pH-sensitive green fluorescent protein (γ 2pHFAP). Live-imaging experiments using γ 2pHFAP GABAAR expressing neurons identified enhanced lysosomal targeting of surface GABAARs and increased overall accumulation in vesicular compartments in response to DZP. Using fluorescence resonance energy transfer (FRET) measurements between α 2 and γ 2 subunits within a GABAAR in neurons, we identified reductions in synaptic clusters of this subpopulation of surface BZD sensitive receptor. Additional time-series experiments revealed the gephyrin regulating kinase ERK was inactivated by DZP at multiple time points. Moreover, we found DZP simultaneously enhanced synaptic exchange of both γ 2-GABAARs and gephyrin using fluorescence recovery after photobleaching (FRAP) techniques. Finally we provide the first proteomic analysis of the BZD sensitive GABAAR interactome in DZP vs. vehicle treated mice. Collectively, our results indicate DZP exposure elicits down-regulation of gephyrin scaffolding and BZD sensitive GABAAR synaptic availability via multiple dynamic trafficking processes.

AB - Despite 50+ years of clinical use as anxiolytics, anti-convulsants, and sedative/hypnotic agents, the mechanisms underlying benzodiazepine (BZD) tolerance are poorly understood. BZDs potentiate the actions of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the adult brain, through positive allosteric modulation of γ 2 subunit containing GABA type A receptors (GABAARs). Here we define key molecular events impacting γ 2 GABAAR and the inhibitory synapse gephyrin scaffold following initial sustained BZD exposure in vitro and in vivo. Using immunofluorescence and biochemical experiments, we found that cultured cortical neurons treated with the classical BZD, diazepam (DZP), presented no substantial change in surface or synaptic levels of γ 2-GABAARs. In contrast, both γ 2 and the postsynaptic scaffolding protein gephyrin showed diminished total protein levels following a single DZP treatment in vitro and in mouse cortical tissue. We further identified DZP treatment enhanced phosphorylation of gephyrin Ser270 and increased generation of gephyrin cleavage products. Selective immunoprecipitation of γ 2 from cultured neurons revealed enhanced ubiquitination of this subunit following DZP exposure. To assess novel trafficking responses induced by DZP, we employed a γ 2 subunit containing an N terminal fluorogen-activating peptide (FAP) and pH-sensitive green fluorescent protein (γ 2pHFAP). Live-imaging experiments using γ 2pHFAP GABAAR expressing neurons identified enhanced lysosomal targeting of surface GABAARs and increased overall accumulation in vesicular compartments in response to DZP. Using fluorescence resonance energy transfer (FRET) measurements between α 2 and γ 2 subunits within a GABAAR in neurons, we identified reductions in synaptic clusters of this subpopulation of surface BZD sensitive receptor. Additional time-series experiments revealed the gephyrin regulating kinase ERK was inactivated by DZP at multiple time points. Moreover, we found DZP simultaneously enhanced synaptic exchange of both γ 2-GABAARs and gephyrin using fluorescence recovery after photobleaching (FRAP) techniques. Finally we provide the first proteomic analysis of the BZD sensitive GABAAR interactome in DZP vs. vehicle treated mice. Collectively, our results indicate DZP exposure elicits down-regulation of gephyrin scaffolding and BZD sensitive GABAAR synaptic availability via multiple dynamic trafficking processes.

KW - Benzodiazepine

KW - Diazepam

KW - GABAR

KW - Gephyrin

KW - Inhibitory synapse

KW - Mass spectrometry

KW - Trafficking

UR - http://www.scopus.com/inward/record.url?scp=85066938905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066938905&partnerID=8YFLogxK

U2 - 10.3389/fncel.2019.00163

DO - 10.3389/fncel.2019.00163

M3 - Article

VL - 13

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

SN - 1662-5102

M1 - 163

ER -